Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors

Journal of Clinical Investigation

Volumn 97, Issue 5, 1996, Pages 1219-1226

  Kumar, Anil ^a   Farace, Françoise ^a   Gaudin, Catherine ^a   Triebel, Frédéric ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

colorectal adenocarcinoma; Interleukin 2; T cell receptor

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; CLINICAL TRIAL; CLONAL ANERGY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN TISSUE; LIVER RESECTION; PHASE 1 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0029962893     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118536     Document Type: Article

References (26)

1. Rosenberg, S.A., M.T. Lotze, J.C. Yang, P.M. Aebersold, W.M. Linehan, C. Seipp, and D.E. White. 1989. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg. 210:474-485.
2. Dillman, R.O., C. Church, R.K Oldham, W.H. West, L. Schwartzberg, and R. Birch. 1993. Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. Cancer (Phila.). 71.2358-2370.
3. Nohria, A , and R.H. Rubin 1994. Cytokines as potential vaccine adjuvants. Biotherapy. 7 261-269
4. Elias, D., F. Farace, F. Triebel, J.M. Hatchouel, J P. Pignon, A. Lecesne, P Rougier, P. Lasser, P. Duvillard, and B. Escudier 1995. Phase I-II randomized study on prehepatectomy rIL-2 immunotherapy in patients with metastatic colorectal cancer. J. Am Coll. Surg. 181:303-310.
5. Soiffer, R.J., C. Murray, R. Gonin, and J. Ritz. 1994 Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood 84:964-971.
6. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
7. Brichard, V , A Van Pel, T Wolfel, C. Wolfel, E. Deplaen, B. Lethe, P. Coulte, and T Boon 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
8. Kawakami, Y., S. Eliyahu, C.H Delgado, P.F Robbins, K Sakaguchi, E. Appella, J.R. Yannelli, G.J Adema, T Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6462.
9. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad Sci. USA 91:3515-3519.
10. Coulie, P.G., V Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E.D. Plaen, C. Lurquin, J.P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med 180:35-42.
11. Mackensen, A., G. Carcelain, S. Viel, M.C. Raynal, H. Michalaki, F. Triebel, J. Bosq, and T. Hercend. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93:1397-1402.
12. Puisieux, I., J. Even, C. Pannetier, F. Jotereau, M. Favrot, and P. Kourilsky 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas J Immunol 153:2807-2818
13. Gaudin, C., P.Y. Dietrich, S. Robache, M. Guillard, B. Escudier, M.J. Terrier-Lacombe, A Kumar, F. Triebel, and A. Caignard. 1995. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res 55.685-690.
14. Caignard, A., P.Y. Dietrich, V. Morand, A. Lim, C. Pannetier, A.M Leirdant, T. Hercend, J. Even, P. Kourilsky, and F. Triebel. 1994 Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck. Cancer Res. 54:1292-1297.
15. Farace, F., F Orlanducci, P.Y. Dietrich, C. Gaudin, E Angevin, M H Courtier, C. Bayle, T. Hercend, and F. Triebel. 1994. T cell repertoire in patients with B-chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansions J. Immunol. 153:4281-4290.
16. Savelieva, E., F. Farace, E. Angevin, D Elias, B. Escudier, P. Duvillard, T. Hercend, and F. Triebel 1994 T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapy. J. Immunother. 16.66-76.
17. Belyavsky, A., T. Vinogradova, and K Rajewsky. 1989. PCR-based cDNA library construction: general cDNA libraries at the level of a few cells. Nucleic Acids Res. 17:2919-2932.
18. Genevee, C., A. Diu, J. Nierat, A Caignard, P.Y Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction Eur. J Immunol. 22:1261-1269.
19. Cochet, M., C. Pannetier, A. Regnault, S. Darche, C Leclerc, and P. Kourilsky. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639-2647.
20. Pannetier, C , M. Cochet, S. Darche, A. Casrouge, M Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90:4319-4323.
21. Dietrich, P Y , A. Caignard, A. Lim, V. Chung, J.L. Pico, C. Pannetier, P Kourilsky, T Hercend, J. Even, and F. Triebel. 1994. In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84:2815-2820.
22. Lotze, M.T., E.A. Grimm, A. Mazumder, J.L. Strausser, and S.A. Rosenberg. 1981. In vitro growth of cytotoxic human lymphocytes Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res. 41:4420-4425.
23. Farace, F., E. Angevin, B. Escudier, A. Caignard, P.Y. Dietrich, C. Genevee, T. Hercend, and F. Triebel. 1993. Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma. Int. J. Cancer. 54:741-747.
24. Farace, F., E. Angevin, P.-Y. Dietrich, C. Leboullaire, J. Vanderplancke, B. Escudier, and F. Triebel. 1995. Low-dose IL-2 treatment: activation of discrete T- and NK-cell sub-populations in vivo. Int. J. Cancer. 62:523-528.
25. Teppler, H., G. Kaplan, K.A. Smith, A.L. Montana, P. Meyn, and Z.A. Cohn 1993. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 177:483-492.
26. Kaplan, G., R. Kiessling, S. Teklemariam, G. Hancock, G. Sheftel, C.K. Job, P. Converse, T.H.M. Ottenhoff, M. Becx-Bleumink, M. Dietz, and Z.A. Cohn. 1989. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin-2. J. Exp. Med. 169: 893-907.